Tech Company Financing Transactions
Sialix Funding Round
On 10/11/2012, Sialix raised $400 thousand in Series B funding from private investors.
Transaction Overview
Company Name
Announced On
10/11/2012
Transaction Type
Venture Equity
Amount
$400,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
90 Bridge St. 100
Newton, MA 02458
USA
Newton, MA 02458
USA
Phone
Website
Email Address
Overview
Sialix is developing products based on new biological discoveries of non-human sialic acids, their dietary role and inflammatory consequences, and their potential impact on cancer, cardiovascular, and other inflammatory-mediated diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Brad Curley
Chief Executive Officer
Jeffrey Behrens
VP - R & D
Daniel Dransfield
Browse more venture capital transactions:
Prev: 10/11/2012: Bright Pattern venture capital transaction
Next: 10/11/2012: SideCar Technologies venture capital transaction
Share this article
Where The Data Comes From
We report on funding rounds that are announced publicly. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs